baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Morgan Stanley Call 160 NVO 16.01.../ DE000ME6KJQ2 /

7/12/2024 9:08:13 PM	Chg.+0.14	Bid10:00:34 PM	Ask10:00:34 PM	Underlying	Strike price	Expiration date	Option type
1.86EUR	+8.14%	- Bid Size: -	- Ask Size: -	Novo Nordisk	160.00 USD	1/16/2026	Call

TeleTrader 7/5 Novo Nordisk slammed over undisclosed payments

GlobeNewswire 7/2 Notified Celebrates Winners of 2024 IR Magazine European Awards

GlobeNewswire 6/28 SNIPR Biome receives funding for the development of CRISPR-medicines to improve Environmental Enteri...

GlobeNewswire 6/27 Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product

GlobeNewswire 6/24 Veru Announces Safety and Body Composition Data from Two Late-Breaker Presentations at the American ...

GlobeNewswire 6/18 Novo Nordisk announces presentation of data from key semaglutide clinical trials in diabetes, obesit...

GlobeNewswire 6/18 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...

GlobeNewswire 6/17 Veru Reminds Shareholders to Vote in Advance of Tomorrow’s Deadline for 2024 Annual Meeting of Share...

TeleTrader 6/15 Novo Nordisk CEO to voluntarily testify before US committee

GlobeNewswire 6/14 Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs

GlobeNewswire 6/13 Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Chil...

GlobeNewswire 6/13 Biosplice Announces Collaboration with Novo Nordisk in Diabetes

GlobeNewswire 6/11 Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next...

GlobeNewswire 6/10 RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships

GlobeNewswire 6/10 Veru to Present at the American Diabetes Association's 84th Scientific Sessions

GlobeNewswire 6/3 Aeterna Zentaris and Ceapro Complete Merger Transaction

GlobeNewswire 5/31 Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia...

GlobeNewswire 5/30 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More

GlobeNewswire 5/22 Veru to Present at the Jefferies Global Healthcare Conference

GlobeNewswire 5/15 Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Cl...

GlobeNewswire 5/15 Aeterna Zentaris Reports First Quarter 2024 Financial Results

GlobeNewswire 5/14 Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Sci...

GlobeNewswire 5/9 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...

GlobeNewswire 5/7 Vect-Horus to Take Part in a Roundtable Discussion at Viva Technology Conference

Morgan Stanley Call 160 NVO 16.01.../ DE000ME6KJQ2 /

If you wish to receive reply to your feedback, please provide your email address.